Novel selective androgen receptor modulators: SAR studies on 6-bisalkylamino-2-quinolinones
Authors:
- Lin ZhiLZLin Zhi
- 1 March 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (6) , 1527-1531
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Discovery of an androgen receptor modulator pharmacophore based on 2-quinolinonesBioorganic & Medicinal Chemistry Letters, 2007
- Pharmacological and X-Ray Structural Characterization of a Novel Selective Androgen Receptor Modulator: Potent Hyperanabolic Stimulation of Skeletal Muscle with Hypostimulation of Prostate in RatsEndocrinology, 2007
- An Orally Active Selective Androgen Receptor Modulator Is Efficacious on Bone, Muscle, and Sex Function with Reduced Impact on ProstateEndocrinology, 2007
- Structure of the ligand-binding domain (LBD) of human androgen receptor in complex with a selective modulator LGD2226Acta Crystallographica Section F Structural Biology and Crystallization Communications, 2006
- Discovery of 6-N,N-Bis(2,2,2-trifluoroethyl)amino- 4-trifluoromethylquinolin-2(1H)-one as a Novel Selective Androgen Receptor ModulatorJournal of Medicinal Chemistry, 2006
- Aromatase Activity and Bone Homeostasis in MenThe Journal of Clinical Endocrinology & Metabolism, 2004
- DIHYDROTESTOSTERONE AND THE PROSTATE: THE SCIENTIFIC RATIONALE FOR 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 2004
- Finasteride in the treatment of alopeciaExpert Opinion on Pharmacotherapy, 2004
- Design, Synthesis, and Biological Characterization of Metabolically Stable Selective Androgen Receptor ModulatorsJournal of Medicinal Chemistry, 2004
- Bone Anabolic Effects of S-40503, a Novel Nonsteroidal Selective Androgen Receptor Modulator (SARM), in Rat Models of OsteoporosisBiological and Pharmaceutical Bulletin, 2003